Ashizawa K - Search Results

1

Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.

Villadolid MC, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K, Kiriyama T, Uetani M, Nagataki S. Villadolid MC, et al. Among authors: ashizawa k. J Clin Endocrinol Metab. 1995 Sep;80(9):2830-3. doi: 10.1210/jcem.80.9.7673432. J Clin Endocrinol Metab. 1995. PMID: 7673432

2

Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.

Yokoyama N, Nagataki S, Uetani M, Ashizawa K, Eguchi K. Yokoyama N, et al. Among authors: ashizawa k. Thyroid. 2002 Mar;12(3):223-7. doi: 10.1089/105072502753600179. Thyroid. 2002. PMID: 11952043 Clinical Trial.

3

Thyroid dysfunction in patients with amyloid goitre.

Kimura H, Yamashita S, Ashizawa K, Yokoyama N, Nagataki S. Kimura H, et al. Among authors: ashizawa k. Clin Endocrinol (Oxf). 1997 Jun;46(6):769-74. doi: 10.1046/j.1365-2265.1997.1841000.x. Clin Endocrinol (Oxf). 1997. PMID: 9274710

4

Prevalence of goiter and urinary iodine excretion levels in children around Chernobyl.

Ashizawa K, Shibata Y, Yamashita S, Namba H, Hoshi M, Yokoyama N, Izumi M, Nagataki S. Ashizawa K, et al. J Clin Endocrinol Metab. 1997 Oct;82(10):3430-3. doi: 10.1210/jcem.82.10.4285. J Clin Endocrinol Metab. 1997. PMID: 9329381

5

Interferon-gamma inhibits thyrotropin-induced thyroidal peroxidase gene expression in cultured human thyrocytes.

Ashizawa K, Yamashita S, Nagayama Y, Kimura H, Hirayu H, Izumi M, Nagataki S. Ashizawa K, et al. J Clin Endocrinol Metab. 1989 Aug;69(2):475-7. doi: 10.1210/jcem-69-2-475. J Clin Endocrinol Metab. 1989. PMID: 2546966

6

Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system.

Tamura M, Kimura H, Koji T, Tominaga T, Ashizawa K, Kiriyama T, Yokoyama N, Yoshimura T, Eguchi K, Nakane PK, Nagataki S. Tamura M, et al. Among authors: ashizawa k. Endocrinology. 1998 Aug;139(8):3646-53. doi: 10.1210/endo.139.8.6140. Endocrinology. 1998. PMID: 9681519

7

Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism.

Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R, Nagataki S, Eguchi K. Imaizumi M, et al. Among authors: ashizawa k. J Clin Endocrinol Metab. 2004 Jul;89(7):3365-70. doi: 10.1210/jc.2003-031089. J Clin Endocrinol Metab. 2004. PMID: 15240616

8

Glucose stimulation of protooncogene expression and deoxyribonucleic acid synthesis in rat islet cell line.

Yamashita S, Tobinaga T, Ashizawa K, Nagayama Y, Yokota A, Harakawa S, Inoue S, Hirayu H, Izumi M, Nagataki S. Yamashita S, et al. Among authors: ashizawa k. Endocrinology. 1988 Oct;123(4):1825-9. doi: 10.1210/endo-123-4-1825. Endocrinology. 1988. PMID: 3416817

9

Improvement of hypothyroidism after glucocorticoid replacement in isolated adrenocorticotropin deficiency.

Tamura M, Yokoyama N, Nishikawa T, Takeshita A, Kimura H, Ashizawa K, Kiriyama T, Nagataki S. Tamura M, et al. Among authors: ashizawa k. Intern Med. 1995 Jun;34(6):559-63. doi: 10.2169/internalmedicine.34.559. Intern Med. 1995. PMID: 7549143 Free article.

10

Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women.

Fujiyama K, Kiriyama T, Ito M, Kimura H, Ashizawa K, Tsuruta M, Nagayama Y, Villadolid MC, Yokoyama N, Nagataki S. Fujiyama K, et al. Among authors: ashizawa k. Thyroid. 1995 Feb;5(1):13-7. doi: 10.1089/thy.1995.5.13. Thyroid. 1995. PMID: 7787427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters